NeuroPace

(NASDAQ) NPCE

Current Price$16.50

Market Cap$592.89M

Since IPO (2021)-30%

5 Year-28%

1 Year+26%

1 Month+0%

NeuroPace Financials at a Glance

Market Cap

$592.89M

Revenue (TTM)

$99.53M

Net Income (TTM)

-$21.57M

EPS (TTM)

-$0.65

P/E Ratio

-26.80

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Price

$16.50

Volume

177,844.32

Open

$17.39

Price

$16.50

Volume

177,844.32

Open

$17.39

Previous Close

$16.54

Daily Range

$16.46 - $17.65

52-Week Range

$7.56 - $19.60

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Price

$16.50

Volume

177,844.32

Open

$17.39

Previous Close

$16.54

Daily Range

$16.46 - $17.65

52-Week Range

$7.56 - $19.60

NPCE News

Two people participating in a telehealth session

NPCE: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NeuroPace

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

209

CEO

Joel D. Becker, MBA

Website

www.neuropace.com

Headquarters

Mountain View, CA 94043, US

NPCE Financials

Key Financial Metrics (TTM)

Gross Margin

78%

Operating Margin

-17%

Net Income Margin

-22%

Return on Equity

-111%

Return on Capital

-20%

Return on Assets

-22%

Earnings Yield

-3.73%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$592.89M

Shares Outstanding

34.09M

Volume

177.84K

Avg. Volume

211.08K

Financials (TTM)

Gross Profit

$77.22M

Operating Income

-$16.34M

EBITDA

-$14.39M

Operating Cash Flow

-$11.01M

Capital Expenditure

-$332.00K

Free Cash Flow

-$11.34M

Cash & ST Invst.

$61.06M

Total Debt

$70.84M

NeuroPace Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$22.07M

-2.0%

Gross Profit

$18.05M

+4.1%

Gross Margin

81.78%

N/A

Market Cap

$592.89M

N/A

Market Cap/Employee

$3.22M

N/A

Employees

184

N/A

Net Income

-$6.69M

-1.5%

EBITDA

-$5.06M

-7.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

-$16.48M

-139.2%

Accounts Receivable

$14.79M

-4.2%

Inventory

$16.69M

+22.9%

Long Term Debt

$68.28M

-4.1%

Short Term Debt

$2.19M

+13.7%

Return on Assets

-21.81%

N/A

Return on Invested Capital

-20.26%

N/A

Free Cash Flow

-$6.02M

+20.0%

Operating Cash Flow

-$5.90M

+21.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CERSCerus Corporation

CERSCerus Corporation$3.04+4.11%

BWAYBrainsWay Ltd.

BWAYBrainsWay Ltd.$15.89+0.06%

DCTHDelcath Systems, Inc.

DCTHDelcath Systems, Inc.$10.78-1.55%

MASS908 Devices Inc.

MASS908 Devices Inc.$8.41-5.82%

SENSSenseonics Holdings, Inc.

SENSSenseonics Holdings, Inc.$6.79+1.04%

SGHTSight Sciences, Inc.

SGHTSight Sciences, Inc.$4.86-3.95%

RXSTRxSight, Inc.

RXSTRxSight, Inc.$5.33-4.65%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCEVirgin Galactic

SPCEVirgin Galactic$6.18+0.36%

SOFISoFi Technologies

SOFISoFi Technologies$18.22+0.07%

ONDSOndas

ONDSOndas$13.22-0.00%

BBAIBigBear.ai

BBAIBigBear.ai$5.04+0.02%

HPEHewlett Packard Enterprise

HPEHewlett Packard Enterprise$43.04+0.13%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.64-0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.92-0.03%

Questions About NPCE

What is the current price of NeuroPace?

NeuroPace is trading at $16.54 per share.

What is the 52-week range for NeuroPace?

Over the past 52 weeks, NeuroPace has traded between $7.56 and $19.60.

How much debt does NeuroPace have?

As of the most recent reporting period, NeuroPace reported total debt of $70.46M.

How much cash does NeuroPace have on hand?

NeuroPace reported $14.78M in cash and cash equivalents in its most recent financial results.

What is NeuroPace’s dividend yield?

NeuroPace does not currently have a dividend yield.

NeuroPace

NeuroPace Financials at a Glance

NPCE News

Why NeuroPace Stock Was Inching Higher on Wednesday

NeuroPace Revenue Jumps 22 Percent in Q2

NeuroPace Reports Record Q2 Revenue

Could This Recently IPOed Medical Device Maker Make You Rich?

NPCE: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About NeuroPace

NPCE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

NeuroPace Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NPCE

What is the current price of NeuroPace?

What is the 52-week range for NeuroPace?

How much debt does NeuroPace have?

How much cash does NeuroPace have on hand?

What is NeuroPace’s dividend yield?

Premium Investing Services